High-dose insulin for liver function after surgery
Part of Digestive system clinical trials.
This trial tests if high-dose insulin can help your liver work better and heal faster after a major liver surgery for colorectal cancer that has spread to the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You are scheduled for a major liver resection (removal of part of your liver).
- Your colorectal cancer has spread to your liver and can be removed with surgery.
- You do not have type 1 diabetes.
- Your blood sugar is well-controlled (fasting level 10 mmol/L or lower).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving high-dose insulin around the time of major abdominal surgery can lower the risk of post-surgery infections. If you’re having elective liver, pancreas, or colorectal surgery, the study looks at whether tighter sugar control helps your recovery.
This study looks at how vitamin D levels—and taking high-dose supplements—affect health differences around the time of liver surgery for liver cancer. It aims to see whether improving vitamin D status can improve outcomes during recovery.
This study tests whether giving insulin after pancreas surgery helps patients who didn't have diabetes before. The pancreas makes insulin, so removing part of it can affect blood sugar control.
This trial tests a two-step liver surgery approach for people with advanced (not fully removable) liver cancer or end-stage liver disease, using chemotherapy first when applicable. The goal is to see if this staged plan can better control disease and allow safer surgery.
This study tests advanced treatments for cancer that has spread to the liver, either from colon cancer or pancreatic cancer. It may help by targeting liver tumors using treatment plans and, for some participants, liver tissue samples.
This study tests a treatment given before surgery for liver cancer that is at high risk of coming back. You would receive a combination of chemotherapy directly into the liver artery (HAIC), a targeted pill (lenvatinib), and an immunotherapy drug (a PD-1 inhibitor) — if a computer model predicts you might benefit.
Hear when a new Liver Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.